10 Blevins T, Pullman J, Malloy J, et al. DURATION-5: Exenatide once  weekly resulted in greater improvements in glycemic control compared with exenatide twice daily in patients with type 2 diabetes. J Clin Endocrinol Metab 2011; 96: 1301–10. 11 DeYoung MB, MacConell L, Sarin V, Trautmann M, Herbert P.  Encapsulation of exenatide in poly-(D,L-lactide-co-glycolide) microspheres produced an investigational long-acting once-weekly formulation for type 2 diabetes. Diabetes Technol Ther 2011; 13: 1145–54. 12 Kim D, MacConell L, Zhuang D, et al. Eﬀ  ects of once-weekly dosing  of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes. Diabetes Care 2007; 30: 1487–93. 13 Zinman B, Gerich J, Buse JB, et al. Eﬃ   cacy and safety of the human  GLP-1 analog liraglutide in combination with metformin and TZD in patients with type 2 diabetes mellitus (LEAD-4 Met+TZD). Diabetes Care 2009; 32: 1224–30.